NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE96962 Query DataSets for GSE96962
Status Public on Feb 14, 2018
Title Analysis of Combined Transcriptomes Identifies Gene Modules Differentially Responding to Pathogenic Stimulation in Vascular Smooth Muscle and Endothelial Cells
Organism Homo sapiens
Experiment type Expression profiling by high throughput sequencing
Summary Smooth muscle cells (SMCs) and endothelial cells (ECs) constitute vasculature media and endothelium, respectively. Current treatments for cardiovascular disease inhibit SMC hyperplasia but also damage the protective endothelial lining, predisposing patients to thrombosis. Therapeutics targeting SMCs without collateral damage to ECs are highly desirable. However, differential (SMCs versus ECs) disease-associated regulations remain poorly defined. We conducted RNA-seq experiments to investigate SMC-versus-EC differential transcriptomic dynamics, following treatment of human primary SMCs and ECs with TNFα or IL-1β, both established inducers of SMC hyperplasia and EC dysfunction. To analyze combined SMC/EC transcriptomes we developed customized algorithms. Induced by TNFα or IL-1β, 212 and 263 genes respectively showed greater up-regulation in SMCs than in ECs (SMC-enriched), while 140 and 204 genes showed greater up-regulation in ECs over SMCs (EC-enriched). Analysis of gene interaction networks identified 5 common hubs and 4 common bottlenecks in the two SMC-enriched gene sets, and 8 hubs and 3 bottlenecks shared in the EC-enriched gene sets. Significantly, four gene modules were formed with these hubs and bottlenecks. While the JUN module (including JUN, KLF5, HIF1A, CXCL8, FOSL1) and FYN module (FYN, JAK2, MAP2, PIK3R3, DAB2, ASAP2) were SMC-enriched, the SMAD3 (SMAD3, CDKN1A, TRAF1, BCL6, CEBPD, TRIB3, ANK3) and XPO1 (XPO1, ETS2, SSH2, NDRG1, GFPT2?) modules were EC-enriched. As these core subnetworks respond to pathogenic stimulation in a SMC-versus-EC differential manner, they may inform potential intervention targets for selective mitigation of SMC hyperplasia without endothelial damage.
 
Overall design In this study, we performed RNA sequencing (RNA-seq) and global analyses of differential SMC-versus-EC transcriptomic responses, to the same pathogenic cytokine stimulant under stringently controlled conditions. The objective was to identify the gene modules (or subnetworks) that are highly up-regulated in SMCs yet little affected or regulated toward the opposite direction in ECs
 
Contributor(s) Wang B, Pan X, Yuan T, Zhang M, Kent KC, Guo L
Citation(s) 29321689
Submission date Mar 23, 2017
Last update date May 15, 2019
Contact name Lianwang Guo
E-mail(s) guo@surgery.wisc.edu
Phone 608-209-2645
Organization name University of Wisconsin at Madison
Department Surgery
Lab GUO
Street address 1111 Highland Avenue
City Madison
State/province WI
ZIP/Postal code 53705
Country USA
 
Platforms (1)
GPL11154 Illumina HiSeq 2000 (Homo sapiens)
Samples (18)
GSM2546857 EC-CTR rep1
GSM2546858 EC-CTR rep2
GSM2546859 EC-CTR rep3
Relations
BioProject PRJNA380228
SRA SRP102361

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE96962_EC-IL-normalized-gene_exp.diff.gz 905.8 Kb (ftp)(http) DIFF
GSE96962_EC-TNF-normalized-gene_exp.diff.gz 906.2 Kb (ftp)(http) DIFF
GSE96962_SMC--TNF-normalized-gene_exp.diff.gz 924.1 Kb (ftp)(http) DIFF
GSE96962_SMC-IL-normalized-gene_exp.diff.gz 909.5 Kb (ftp)(http) DIFF
SRA Run SelectorHelp
Raw data are available in SRA
Processed data are available on Series record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap